相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Edmond M. Cronin et al.
JOURNAL OF ARRHYTHMIA (2019)
Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement
Rui Liu et al.
MEDICINE (2017)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Interaction of quercetin and its metabolites with warfarin: Displacement of warfarin from serum albumin and inhibition of CYP2C9 enzyme
Miklos Poor et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Effect of CYP2C9-VKORC1 Interaction on Warfarin Stable Dosage and Its Predictive Algorithm
Xi Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The effect of CYP2C9, VKORC1 and CYP4F2 polymorphism and of clinical factors on warfarin dosage during initiation and long-term treatment after heart valve surgery
Vacis Tatarunas et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)
Effect of age and sex on warfarin dosing
Ghada Khoury et al.
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS (2014)
Influence of adult age on the total and free clearance and protein binding of (R)- and (S)-warfarin
Berit Packert Jensen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients
Ruijuan Liang et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2012)
Functional promoter polymorphism in the VKORCI gene is no major genetic determinant for coronary heart disease in Northern Germans
Matthias Watzka et al.
THROMBOSIS AND HAEMOSTASIS (2007)
分享论文
